Cover Image

Tanshinone IIA: A Review of its Anticancer Effects

Tanshinone IIA (Tan IIA) is a pharmacologically lipophilic active constituent isolated from the roots and rhizomes of the Chinese medicinal herb Salvia miltiorrhiza Bunge (Danshen). Tan IIA is currently used in China and other neighboring countries to treat patients with cardiovascular system, diabe...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zhong‐ying Fang (Author), Miao Zhang (Author), Jia-ning Liu (Author), Xue Zhao (Author), Yong-qing Zhang (Author), Lei Fang (Author)
Format:	Book
Published:	Frontiers Media S.A., 2021-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and Safety of Sodium Tanshinone IIA Sulfonate Injection on Hypertensive Nephropathy: A Systematic Review and Meta-Analysis
by: Junyao Xu, et al.
Published: (2019)

Preparation and characterisation of solid dispersions of tanshinone IIA, cryptotanshinone and total tanshinones
by: Xifeng Zhai, et al.
Published: (2017)

Mechanism Study of the Protective Effects of Sodium Tanshinone IIA Sulfonate Against Atorvastatin-Induced Cerebral Hemorrhage in Zebrafish: Transcriptome Analysis
by: Zhong-Yan Zhou, et al.
Published: (2020)

A systematic review and meta-analysis on sodium tanshinone IIA sulfonate injection for the adjunctive therapy of pulmonary heart disease
by: Huikai Shao, et al.
Published: (2024)

Sodium tanshinone IIA sulphate inhibits angiogenesis in lung adenocarcinoma via mediation of miR-874/eEF-2K/TG2 axis
by: Bu Wang, et al.
Published: (2023)

Effect of Tanshinone IIA on Gut Microbiome in Diabetes-Induced Cognitive Impairment
by: Yanfang Zheng, et al.
Published: (2022)

Tanshinone IIA: a Chinese herbal ingredient for the treatment of atherosclerosis
by: Chunkun Yang, et al.
Published: (2023)

Pharmacological Activity and Mechanism of Tanshinone IIA in Related Diseases
by: Guo R, et al.
Published: (2020)

Recent Research Progress (2015-2021) and Perspectives on the Pharmacological Effects and Mechanisms of Tanshinone IIA
by: Chenhui Zhong, et al.
Published: (2021)

Effect of tanshinone IIA for myocardial ischemia/reperfusion injury in animal model: preclinical evidence and possible mechanisms
by: Peng-Chong Zhu, et al.
Published: (2023)

Tanshinone IIA alleviates atherosclerosis in LDLR−/− mice by regulating efferocytosis of macrophages
by: Jiarou Wang, et al.
Published: (2023)

Potential pharmacological mechanisms of tanshinone IIA in the treatment of human neuroblastoma based on network pharmacological and molecular docking Technology
by: Ning Tang, et al.
Published: (2024)

Tanshinone IIA delays liver aging by modulating oxidative stress
by: Qi Liu, et al.
Published: (2024)

Multifunctional icariin and tanshinone IIA co-delivery liposomes with potential application for Alzheimer's disease
by: Jiao Wang, et al.
Published: (2022)

Enhanced production of tanshinone IIA in endophytic fungi Emericella foeniculicola by genome shuffling
by: Pengyu Zhang, et al.
Published: (2018)

Inhibition of tanshinone IIA on renin activity protected against osteoporosis in diabetic mice
by: Jingjing Zhang, et al.
Published: (2020)

Combination of puerarin and tanshinone IIA alleviates ischaemic stroke injury in rats via activating the Nrf2/ARE signalling pathway
by: Qing Miao, et al.
Published: (2022)

Inhibitory effects of tanshinones towards the catalytic activity of UDP-glucuronosyltransferases (UGTs)
by: Xu-Xin Zhang, et al.
Published: (2017)

Unveiling the therapeutic potential and nanotechnological approaches for the delivery of tanshinone IIA
by: Diya Arora, et al.
Published: (2024)

Tanshinone IIA inactivates Akt and induces caspase-dependent death in cervical cancer cells via the mitochondrial pathway
by: Hu Li, et al.
Published: (2015)

Investigation of the mechanism of tanshinone IIA to improve cognitive function via synaptic plasticity in epileptic rats
by: Chen Jia, et al.
Published: (2023)

Tanshinone IIA, a melanogenic ingredient basis of Salvia miltiorrhiza Bunge
by: Zhaojing Wang, et al.
Published: (2021)

Antifatigue properties of tanshinone IIA in mice subjected to the forced swimming test
by: Chueh-Yu Lin, et al.
Published: (2017)

Improvement of Bioavailability and Dissolution of Tanshinone IIA by Encapsulating it with Hydroxypropyl-β-Cyclodextrin
by: Jie Yu, et al.
Published: (2020)

The Anticancer Properties of Tanshinones and the Pharmacological Effects of Their Active Ingredients
by: Li Fu, et al.
Published: (2020)

Tanshinone IIA inhibits osteoclastogenesis in rheumatoid arthritis via LDHC-regulated ROS generation
by: Qiuwei Peng, et al.
Published: (2023)

Tanshinone IIA attenuates AOM/DSS-induced colorectal tumorigenesis in mice via inhibition of intestinal inflammation
by: Lijie Liu, et al.
Published: (2021)

Effects of sodium tanshinone IIA sulfonate injection on inflammatory factors and vascular endothelial function in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A systematic review and meta-analysis of randomized clinical trials
by: Zunqi Kan, et al.
Published: (2023)

Cell Lung Cancer Proliferation Downregulation by Tanshinone IIA: A Systematic Review and Meta-analysis
by: Farzad Amiri, et al.
Published: (2024)

Nose-to-brain delivery of borneol modified tanshinone IIA nanoparticles in prevention of cerebral ischemia/reperfusion injury
by: Luting Wang, et al.
Published: (2021)

Tanshinone IIA Ameliorates Streptozotocin-Induced Diabetic Nephropathy, Partly by Attenuating PERK Pathway-Induced Fibrosis
by: Xu S, et al.
Published: (2020)

Analysis of tanshinone IIA induced cellular apoptosis in leukemia cells by genome-wide expression profiling
by: Liu Chang, et al.
Published: (2012)

Tanshinone IIA alleviates ovalbumin-induced allergic rhinitis symptoms by inhibiting Th2 cytokine production and mast cell histamine release in mice
by: Qing Chen, et al.
Published: (2022)

Maintaining the Mitochondrial Quality Control System Was a Key Event of Tanshinone IIA against Deoxynivalenol-Induced Intestinal Toxicity
by: Cong Zhang, et al.
Published: (2024)

Anticancer Effect of Tanshinones on Female Breast Cancer and Gynecological Cancer
by: Zhou Jin, et al.
Published: (2022)

Sodium Tanshinone IIA Sulfonate as a Potent IDO1/TDO2 Dual Inhibitor Enhances Anti-PD1 Therapy for Colorectal Cancer in Mice
by: Rongjie Zhang, et al.
Published: (2022)

Exploration of Multiple Signaling Pathways Through Which Sodium Tanshinone IIA Sulfonate Attenuates Pathologic Remodeling Experimental Infarction
by: Shuai Mao, et al.
Published: (2019)

Tanshinone IIA ameliorates dextran sulfate sodium-induced inflammatory bowel disease via the pregnane X receptor
by: Zhang X, et al.
Published: (2015)

The combination of Tanshinone IIA and Astragaloside IV attenuates myocardial ischemia-reperfusion injury by inhibiting the STING pathway
by: Pan Zhai, et al.
Published: (2024)

Tanshinone IIA Inhibits Epithelial-to-Mesenchymal Transition Through Hindering β-Arrestin1 Mediated β-Catenin Signaling Pathway in Colorectal Cancer
by: Qing Song, et al.
Published: (2020)